AUROBINDO PHARMA LTD
Long
Updated

AUROPHARMA NSE BULLISH FLAG /RBC&H 7M

257
AUROPHARMA WTF Analysis

TRADE PLAN
ENTRY -1510 -1550 On BO of Bullish Fage DTF Close
SL -1405 or Weekly Low Close Price
TARGET --01-1719 , TGT02--1931
Hold For a Year or TGT 2

Chart Pattern :
STOCK has recently touched its LTH of 1592. Previously Impulse after forming a 2Y-7M RBC on the DTF/WTF. The recent 7Month Swing has now ripened to a Bullish Flag Pattern on a Pullback ready to BO above 1510. The Swing Target to the Recent ATH will give 12%+ return,

INDICATORS EMA :
The Price is Currently Trading below 20EMA, and 20EM above 50EMA in DTF. STOCK EMAs are currently aligned in a ascending order 200 to 20 indicating a bullish Trend on DTF/WTF.

FIBO E :
After the Bounce-back from 23.6% FIBO Retracement Level, Price is currently trading near the 11490 on DTF Impulse uptrend
Volumes: There CURRENTLY not Encouraging Though on the Weekly timeframe

Keep in your Priority Watch List

Disclaimer: For Education/Reference Purpose Only, Trade at your Own Risk with correct position sizing and SL based on your Risk apetite (Exit when price closes 7to8% below your Entry).
Trail Your SL progressively. Learn/Know and Review the Stock trading Technical Terminology. Check Verify the Financial fundamentals of the Stock and Seek Advice from a Certified Financial Advisor prior to Investing. Prefer Entry with 25% quantity, Add in Tranches of 25%-50% as prices moves upwards recommended.


MTFA- Multiple Time Frame Analysis
DTF -Daily Time Frame
WTF-Weekly Time Frame
MTF- Monthly Time Frame
ATH-All Time High
LTH/ATH -LifeTime High
RBC&H-Rounding Bottom Cup/Handle
BO- Breakout Close
EMA -Exponential Moving Average
FIBO R/E -Trend based Fibonacci Retracement/Extension
SL Stop Loss
TBD- To be Decided
CHoCH- Change of Character Bullish/Bearish
MSB/BOS -Break Out Structure
FVG Fair Value Gap
20VMA -20Volume Moving Average
SWING/POSITIONAL Trade
Trade closed: stop reached
SL HIT Close Trade Wait of ReEntry

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.